Merck encourages constant curiosity among its employees and ... improving and prolonging people’s lives. Towards this, it explores new AI-based technologies, products and services that could impact ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

Hundreds of people have been killed and tens of thousands of Palestinians have fled to Gaza City in the latest wave of displacement in the yearlong war. Aid groups have warned of a catastrophic ...

But by the end of the decade, the company should be on its way to replacing Keytruda as its now sold with a new formulation of the medicine. And Merck's business extends beyond this single product.

RAHWAY: Merck, also known as MSD outside the US and Canada, announced that the European Commission (EC) has approved two new indications for KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, in ...

Highlights,Merck gains two new EU approvals for KEYTRUDA in gynecologic cancers.,Approvals cover treatments for advanced endometrial and cervical cancers.,Clinical trials show significant benefits in ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved two new indications for KEYTRUDA ® (pembrolizumab), Merck ...

Credit: eamesBot via Shutterstock. Alpha-9 Oncology is the latest radiopharma to raise funds, drawing in $175m in Series C financing, to advance its radiopharmaceutical candidates through clinical ...

Initially, it was believed to feature a continuously variable automatic (CVT), then rumors of a manual surfaced—only to be promptly shut down. Now, the latest chatter hints that Honda may be ...

The company benefited from rapid international launches. Merck’s new pneumococcal vaccine, CAPVAXIVE, received FDA approval and an ACIP recommendation, while its acquisition of EyeBio marks a ...